John Cioffi

John Cioffi is a Managing Director in UBS Global Wealth Management in New York, where he works as a Senior Portfolio Manager and International Financial Advisor. He has spent more than 30 years in the investment-advisory business. He began his career at Merrill Lynch in 1989 — described in his firm biography as one of the firm's youngest stockbrokers at the time — and spent over two decades there before moving to UBS in July 2016. His day-to-day work is managing discretionary portfolios and wealth for private clients; he is registered as a broker/advisor in New York and a long list of other states (including AZ, CA, CO, CT, FL, GA, MA, MD, MI, NC, NJ, OH, PA and VA).

He earned a B.S. in Finance, magna cum laude, from the University of Notre Dame in 1987. Bio material tied to him notes that he played four years of varsity baseball at Notre Dame and was a multiple-time Academic All-American selection. Alongside his UBS role he holds the internal UBS designations of Senior Portfolio Manager (Portfolio Management Program) and International Financial Advisor.

Separately from his institutional role at UBS, Cioffi has made personal angel investments in early-stage companies, beginning around 2020–2021. Startup databases (PitchBook, Tracxn, Foundersuite) profile him as an angel investor with a small, concentrated portfolio spanning consumer goods, healthcare and telecom, and with a geographic reach into both the U.S. and India.

Important disambiguation: John Cioffi is a common name, and several public profiles conflate at least two different people. The subject here is the *UBS wealth-management Managing Director* ([hidden]). He should not be confused with Dr. John M. Cioffi, the Stanford Professor Emeritus and Chairman/CEO of ASSIA known as "the father of DSL," who is Chairman of PhyTunes. Because of that overlap, some aggregators appear to have merged the two records — see the note under Notable Investments below.

• Invests his own capital as an angel at the seed stage, not through a UBS-branded fund; the wealth-management day job and the personal angel activity are distinct.
• Relationship-driven deal sourcing: his clearest confirmed deal (Soothe Healthcare) came through a founder from his own professional orbit — Soothe's founder Sahil Dharia previously worked on the buy-side at UBS Investment Bank in New York. Warm, network-based connections appear to be how he gets to "yes."
• Sector tilt toward consumer goods / personal-hygiene brands and healthcare, with at least one telecom/5G-adjacent deal on his aggregated record.
• Cross-border appetite: willing to back companies outside the U.S. (notably India), unusual for a U.S. private-wealth advisor investing personally.
• No publicly stated check size or formal thesis in his own words could be verified; treat the seed-stage / small-portfolio framing as coming from third-party databases rather than a self-published mandate.